NEW YORK (GenomeWeb) – The National Institutes of Health has awarded an MD Anderson Cancer Center team a one-year grant to follow up on preliminary data suggesting that certain microRNAs can be used as biomarkers to identify pancreatic neoplasms at high risk for progressing into invasive tumors.

Intraductal papillary mucinous neoplasms, or IPMNs, are cystic lesions that frequently, but not always, progress into pancreatic ductal adenocarcinoma (PDAC).

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.